Intracranial pressure monitoring market drivers and analysis

The process of treating variety of neurological conditions, including severe traumatic brain injury, stroke, and brain bleeds is known as intracranial pressure monitoring. The global intracranial pressure monitoring market was worth $1.38 billion in 2021, and by 2030 it will reach $2.37 with a CAGR of 6.2% throughout the forecast period.

The factors accelerating the growth of this market are the increasing incidence of neurological disorders, technological developments, and the rapidly increasing geriatric population, mainly in the Asia Pacific, especially in Japan, China, and India.  

Market Drivers

An increase in people suffering from neurological illness sufferers is a major driver of the global intracranial pressure monitoring market. 

Furthermore, the increasing number of traumatic bone injuries resulting from broken bones, loss of skull elasticity, and increasing road accidents are additional factors stimulating the market growth. TBI affects over 2.8 million people in the United States yearly, with nearly 280,000 requiring hospitalization, according to the BIAA. The CDC reported that in 2020, there were 176 deaths per day in the US due to TBI, with people over the age of 75 accounting for 28% of the fatality rates. 

According to the World Health Organization, 1.3 million people perish in car accidents yearly, and nearly 1 billion adults are at risk for hearing impairment. Teenagers, young adults, and the elderly are at the greatest risk of TBI-related injuries, according to the BIAA, which reports that falls are the leading cause of brain injury, accounting for 47.9% of TBIs.

Factors restraining the Intracranial Pressure monitoring market

The high cost of ICP monitoring devices and the lack of skilled experts to operate them restricts the overall growth of the market.

Key opportunity

According to one of BIAA’s reports, approximately 5.3 million people worldwide have a TBI-related impairment, or one out of every 60 people. Therefore, there is a significant opportunity for this market to expand due to the growing awareness of neurological disorders and the strategic merger and acquisition between the key players.

Manufacturers in emerging economies such as Japan and India will see rapid growth in their businesses owing to a rise in the geriatric population, which is more prone to neurological disorders. According to the World Health Organization, by 2050, the number of people over 60 will be 22%, nearly double what it was in 2015.

Improvements in intracranial pressure monitoring models such as anterior fontanelle pressure monitoring, and continuous brain tissue oxygen tension monitoring, are improving pathophysiology, and ICH, which is treated by external ventricular drainage, is the result of diligent R&D. This opens up a massive growth opportunity for the market.

Segmentation of intracranial process monitoring

• On the basis of technique, the ICP monitoring market is segmented into invasive intracranial pressure monitoring, external ventricular drainage, and microtransducer ICP monitoring.

The invasive techniques segment recorded the largest market share of 80.9% for intracranial pressure monitoring devices in 2021. Since they are patient-friendly, noninvasive intracranial pressure measurement techniques like venous ophthalmodynamometry are becoming more popular. Infection and hemorrhagic consequences are frequently associated with intrusive monitoring techniques, prompting a widespread search for noninvasive substitutes. 

• The ICP monitoring devices market is segmented into a subarachnoid hemorrhage, intracerebralhemorrhage, traumatic brain injury, hydrocephalus, CNS infections, cerebral edema, hydrocephalus, malignant cerebral infraction, CNS infections, and others based on application.

The traumatic brain injury segment held a significant position in the market and recorded a maximum revenue share of 31.6% in 2021. TBI causes an increase in intracranial pressure, which can be monitored using intracranial pressure monitoring with an intraparenchymal pressure monitor. 

• On the basis of end-user, the ICP monitoring market is segmented into trauma centers, hospitals, ambulatory surgical centers, and neurosurgery centers.

The hospital industry currently holds the largest market share, and it is anticipated that during the anticipated time, it will grow quickly. Trauma centers will likely increase their market share significantly in the upcoming years.

• Regionally, In 2021, North America held the largest revenue share of 37.6% in the global market for intracranial pressure monitoring devices. The rising availability of technologically advanced devices, rising demand for minimally invasive surgeries, and rising adoption of noninvasive ICP monitoring techniques are some of the major factors anticipated to support market growth in this region. The market for intracranial pressure market is expected to be driven by the rising number of trauma cases and rising incidence of migraine, stroke, and other neurological disorders. According to the Brain Trauma Foundation, traumatic brain injury (TBI) accounts for about 30% of all injury-related deaths and is a major cause of mortality and morbidity in the United States.

Furthermore, Asia Pacific will be the fastest-growing market for intracranial pressure monitoring devices and will grow at a CAGR of 7.67% during the forecast period.

Major Players

• Integra Lifesciences Corporation
• Medtronic Plc.
• Sophysa Ltd
• Natus Medical Incorporated
• Focus Medical Group Inc.
• Headsense Medical Inc.
• DePuySynthes
• Gaeltec Devices Ltd
• Linet
• Other players